X-111724973-A-T

Variant summary

Our verdict is Likely benign. The variant received -5 ACMG points: 0P and 5B. BP4BS2

The NM_001099922.3(ALG13):​c.1641A>T​(p.Gln547His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000182 in 1,097,277 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 2 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. Q547P) has been classified as Uncertain significance.

Frequency

Genomes: not found (cov: 23)
Exomes 𝑓: 0.0000018 ( 0 hom. 2 hem. )

Consequence

ALG13
NM_001099922.3 missense

Scores

7
10

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 1.02

Publications

2 publications found
Variant links:
Genes affected
ALG13 (HGNC:30881): (ALG13 UDP-N-acetylglucosaminyltransferase subunit) The protein encoded by this gene is a subunit of a bipartite UDP-N-acetylglucosamine transferase. It heterodimerizes with asparagine-linked glycosylation 14 homolog to form a functional UDP-GlcNAc glycosyltransferase that catalyzes the second sugar addition of the highly conserved oligosaccharide precursor in endoplasmic reticulum N-linked glycosylation. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2009]
ALG13 Gene-Disease associations (from GenCC):
  • genetic developmental and epileptic encephalopathy
    Inheritance: XL Classification: DEFINITIVE Submitted by: ClinGen
  • developmental and epileptic encephalopathy, 36
    Inheritance: XL Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: Orphanet, Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P
  • non-syndromic X-linked intellectual disability
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -5 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.3221457).
BS2
High Hemizygotes in GnomAdExome4 at 2 XL gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ALG13NM_001099922.3 linkc.1641A>T p.Gln547His missense_variant Exon 15 of 27 ENST00000394780.8 NP_001093392.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ALG13ENST00000394780.8 linkc.1641A>T p.Gln547His missense_variant Exon 15 of 27 2 NM_001099922.3 ENSP00000378260.3

Frequencies

GnomAD3 genomes
Cov.:
23
GnomAD4 exome
AF:
0.00000182
AC:
2
AN:
1097277
Hom.:
0
Cov.:
29
AF XY:
0.00000551
AC XY:
2
AN XY:
362737
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
26378
American (AMR)
AF:
0.00
AC:
0
AN:
35192
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19370
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30193
South Asian (SAS)
AF:
0.00
AC:
0
AN:
54085
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
40510
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4133
European-Non Finnish (NFE)
AF:
0.00000238
AC:
2
AN:
841362
Other (OTH)
AF:
0.00
AC:
0
AN:
46054
GnomAD4 genome
Cov.:
23

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Developmental and epileptic encephalopathy, 36 Uncertain:1
Feb 24, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces glutamine, which is neutral and polar, with histidine, which is basic and polar, at codon 547 of the ALG13 protein (p.Gln547His). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with ALG13-related conditions (PMID: 27781031). ClinVar contains an entry for this variant (Variation ID: 1410727). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.26
BayesDel_addAF
Benign
-0.076
T
BayesDel_noAF
Benign
-0.35
CADD
Benign
21
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.78
D;.;.;.;.;T
FATHMM_MKL
Uncertain
0.88
D
LIST_S2
Benign
0.80
T;T;.;T;.;T
M_CAP
Benign
0.075
D
MetaRNN
Benign
0.32
T;T;T;T;T;T
MetaSVM
Benign
-0.88
T
MutationAssessor
Uncertain
2.1
M;.;.;.;.;.
PhyloP100
1.0
PrimateAI
Benign
0.42
T
PROVEAN
Uncertain
-3.0
D;.;D;.;.;.
REVEL
Benign
0.17
Sift
Uncertain
0.0060
D;.;D;.;.;.
Sift4G
Uncertain
0.0070
D;D;D;D;D;D
Polyphen
1.0
D;D;D;D;D;.
Vest4
0.46
MutPred
0.40
Loss of catalytic residue at Q547 (P = 0.0079);.;.;.;.;.;
MVP
0.79
MPC
0.69
ClinPred
0.94
D
GERP RS
3.1
Varity_R
0.23
gMVP
0.47
Mutation Taster
=82/18
polymorphism

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs768589790; hg19: chrX-110968201; API